Global Vaccines Market Size By Age Group (Pediatric, Adult), By Technology (Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant,), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), Regional Outlook (U.S., Canada, Germany, UK, Spain, Russia, Italy, France, China, Japan, India, Indonesia, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Qatar, Egypt), Technology Development, Competitive Landscape & Forecast, 2017 – 2024
Published Date: November 2017 | 140 Pages | Report ID: GMI2186 | Report Format:
Global Vaccines Market size was valued over USD 32 billion in 2016 and is expected to witness more than 9% CAGR from 2017 to 2024.
U.S. Vaccines Market, By Age Group, 2013 - 2024 (USD Billion)
Rising prevalence of several infectious and non-infectious diseases globally coupled with increasing funding for vaccine development will drive the vaccines market size. Growing demand for preventive vaccines, rising awareness coupled with mounting demand among the developing countries should boost the business revenue.
Immunization currently prevents an estimated 2 to 3 million deaths every year. Furthermore, additional 1.5 million deaths could be evaded through improved global vaccination coverage. Increasing uptake of new and underused vaccines will prominently intensify its global usage over the forecast years.
Technological advances, rising demand for low cost products and widespread routine vaccination programmes in emerging economies will stimulate the business growth. Increasing demand for combined vaccines that offers immunization against several diseases, growing initiatives for production of low cost vaccines will further boost the industry growth.
Growing adoption of cancer therapeutic vaccines, improved patient compliance along with mounting product pipeline will drive the business growth. Growing efforts to help avert adverse reactions and adoption of appropriate preventive screening methods will propel the business size.
Prohibitive cost associated with storage and transportation of vaccines will restrain the industry growth. Limited reimbursement coverage and stringent government regulations for the approval of products will further hamper the business expansion over the coming years.
Global Vaccines Market, By Age Group
Paediatric accounted for significant revenue share in 2016 and is forecast to witness substantial growth over the forecast years. Improved level of vaccine recommendation by CDC for monotonous immunization for children below 6 years will fuel the business growth. Therapeutic is set to witness significant growth owing to its vital role in cancer treatment by boosting the vaccines' influence through merging them with treatments that target the immune system.
Global Vaccines Market, By Technology
Conjugate segment held the largest market share in 2016 and will continue to be most used technology over the forecast period. The ability to reduce asymptomatic carriage of the bacteria and produce immunological memory, better-quality memory and long-lasting protection will boost the industry size.
Global Vaccines Market, By Disease
Cancer segment will grow at a significant rate owing to the ability of vaccines by protecting immune system to control, or get rid of, an otherwise difficult to treat condition. Influenza disease segment are estimated to grow at noteworthy rate over the coming years. Growing disease prevalence in emerging economies coupled with increased disease mortality will boost the segment growth.
Global Vaccines Market, By Region
U.S. vaccines market accounted for largest regional share in 2016. Growing initiatives by HHS to reduce infectious diseases by increasing immunization rates and immunization recommendations will fuel the business size. For instance, the Healthy People 2020 aims for immunization to prevent and treat infectious diseases.
Germany will grow at a considerable rate over the coming years owing to increasing government initiatives to offer medical advice for the vaccinating children. Rising prevalence of infectious diseases and focused product development will fuel industry expansion.
Asia Pacific will witness significant growth over the forecast period due to increasing awareness for prevention of diseases, improving economic settings and growing adoption for advanced technology should accelerate regional revenue share.
Competitive Market Share
Some of the major players in vaccines market are AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Novartis, Astellas Pharma, CSL and Novavax. Industry players focus on new product development, mergers, and acquisition to strengthen their market position. Companies should face intense competition for development of novel products.
Global Vaccines Industry Background
Vaccines market is highly fragmented with presence of few big market players offering wide range of products so far and are focusing of increasing pipeline products. Industry players will mainly emphasize on development of combined vaccines over the coming years. The industry is projected to undergo momentous expansion over the next decade.
What Information does this report contain?
Why Global Market Insights?
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security